26308-39-4 Usage
Uses
Used in Pharmaceutical Industry:
1-Ethyl-3-methyl-4-nitro-1H-pyrazole-5-carboxylic acid is used as a key intermediate in the synthesis of various drugs and medicines. Its unique chemical properties allow it to be incorporated into the development of new therapeutic agents, enhancing their efficacy and safety.
Used in Medicinal Chemistry Research:
1-Ethyl-3-methyl-4-nitro-1H-pyrazole-5-carboxylic acid is utilized as a research tool in medicinal chemistry to explore its potential as a therapeutic agent. Its ability to inhibit certain biological processes makes it a valuable compound for investigating its effects on specific medical conditions and identifying potential applications in treatment.
Used in Drug Development:
1-Ethyl-3-methyl-4-nitro-1H-pyrazole-5-carboxylic acid is employed in drug development as a starting material for the creation of novel pharmaceuticals. Its unique structure and properties can be leveraged to design and synthesize new drugs with improved therapeutic profiles, targeting a range of medical conditions.
Used in Drug Discovery:
1-Ethyl-3-methyl-4-nitro-1H-pyrazole-5-carboxylic acid is used in drug discovery as a potential lead compound for the development of new therapeutic agents. Its ability to modulate biological processes and its unique chemical properties make it an attractive candidate for further research and optimization to enhance its therapeutic potential.
Used in Targeted Drug Delivery Systems:
1-Ethyl-3-methyl-4-nitro-1H-pyrazole-5-carboxylic acid can be used in the development of targeted drug delivery systems, where its unique properties can be harnessed to improve the delivery of therapeutic agents to specific tissues or cells. This can lead to enhanced efficacy and reduced side effects, improving patient outcomes.
Used in Combination Therapies:
1-Ethyl-3-methyl-4-nitro-1H-pyrazole-5-carboxylic acid may be used in combination therapies, where its ability to inhibit certain biological processes can be leveraged alongside other therapeutic agents to achieve synergistic effects. This can lead to improved treatment outcomes and potentially overcome drug resistance in certain medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 26308-39-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,3,0 and 8 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 26308-39:
(7*2)+(6*6)+(5*3)+(4*0)+(3*8)+(2*3)+(1*9)=104
104 % 10 = 4
So 26308-39-4 is a valid CAS Registry Number.
InChI:InChI=1/C7H9N3O4/c1-3-9-6(7(11)12)5(10(13)14)4(2)8-9/h3H2,1-2H3,(H,11,12)
26308-39-4Relevant academic research and scientific papers
Synthesis and antitumor activity of a new class of pyrazolo[4,3- e]pyrrolo[1,2-a][1,4]diazepinone analogues of pyrrolo[1,4][2,1- c]benzodiazepines
Baraldi,Leoni,Cacciari,Manfredini,Simoni,Bergomi,Menta,Spinelli
, p. 4329 - 4337 (2007/10/02)
A new class of pyrrolo[1,4]benzodiazepine (PBD) analogues featuring a pyrazolo[4,3-e]pyrrolo[1,2-a][1,4]diazepinone ring system has been designed and synthesized. These compounds, 2a-o, are characterized by the substitution of the aromatic A ring, characteristic of the PBDs, with a disubstituted pyrazole ring bearing alkyl and benzyl substituents at N6 or N7 and alkyl or carbomethoxy substituents at C8. Biological evaluation revealed an appreciable in vitro cytotoxic activity for compounds 2a,b,f-i.
Pyrazolodiazepines. 1,3 (and 2,3) dialkyl 4,6 dihydro 8 arylpyrazolo[4,3 e][1,4] diazepin 5 ones as antianxiety agents
DeWald,Nordin,L'Italien,Parcell
, p. 1346 - 1354 (2007/10/04)
A series of 1, 3 (and 2, 3) dialkyl 4, 6 dihydro 8 arylpyrazolo [4, 3 e][1, 4] diazepin 5 ones was synthesized and evaluated for psychotropic activity. Intermediates are new dialkylnitropyrazolyl aryl ketones prepared from dialkylnitropyrazolecarboxylic acids. Many of these pyrazolodiazepines exhibit high CNS activity in animals. One compound, 1 ethyl 4, 6 dihydro 3 methyl 8 phenylpyrazolo [4, 3 e] [1, 4] diazepin 5 (1H) one is about as potent as diazepam as an antianxiety agent with less sedative properties and is being studied in the clinic.
